Persistent Circulating SARS-CoV-2 Spike is Associated with Post-acute COVID-19 Sequelae

Zoe Swank, Yasmeen Senussi, Galit Alter, David R. Walt

The diagnosis and management of post-acute sequelae of COVID-19 (PASC) poses an
ongoing medical challenge … [T]emporal antigen profiles for many patients show the
presence of spike at multiple time points over several months, highlighting the potential
utility of the SARS-CoV-2 full spike protein as a biomarker for PASC.

… We analyzed plasma samples from a cohort of 63 individuals previously infected with
SARS-CoV-2, 37 of whom were diagnosed with PASC.

… Most notably, we detected circulating SARSCoV-2 spike in the majority of PASC patients, but in none of the COVID-19 patients.

… In conclusion, the presence of circulating spike in PASC patients up to 12 months
post-diagnosis strongly suggests that SARS-CoV-2 viral reservoirs persist in the body.
Additionally, the detection of spike in a majority of individuals included in our PASC cohort
provides strong support for the use of spike as a biomarker for PASC. If PASC patients
can be identified based on the direct measurement of spike protein, characterizing patient
phenotypes and assessing treatment strategies will become increasingly effective.

Latest articles

The Goddard Report A podcast with Dr. Stephen Malthouse on “Making Doctors... All previous outbreaks, epidemics and pandemics end when Community Immunity, NOT...
Amanuensis Variants have been one of the hallmarks of this pandemic, with...
Samuel Reinfeld et al. The COVID-19 pandemic continues to have a deleterious...

Thank you!

Thank you for your membership application. As soon as your payment has been received your membership will be activated and you will be informed via email.

Thank you.

Thank you!

The form has been submitted successfully!